Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study

Alexander J. M. Brown, Chim Lang, Rory McCrimmon, Allan Struthers (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)
195 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences